Back to search

National and Kapodistrian University of Athens

Διερεύνηση της προσβασιμότητας των υπηρεσιών υγείας από ασθενείς με κακοήθη νεοπλασματική νόσο και εκτίμηση της οικονομικής επιβάρυνσης του ΕΟΠΥΥ

Abstract

dc:description

Introduction: Cancer is a major public health issue and imposes a significant economic burden that affects the sustainability of healthcare systems. Study Objective: Given the lack of information (from a National Cancer Registry) about the pathways of oncology patients in the healthcare system, this thesis aims to investigate the equitable use of healthcare resources by oncology patients and to assess the resulting perspective of the National Organization for the Provision of Health Services (EOPYY) in Greece. Methodology: A retrospective study was conducted using anonymized administrative healthcare data from the EOPYY and the Social Security Electronic Government (HDIKA) databases. The analysis focused on EOPYY care beneficiaries who were diagnosed for the first time in 2017 with breast (BC), lung (LC), prostate (PC) and colon (CRC) cancer. Through healthcare resource utilization data and the development of logical algorithms, the number of newly diagnosed patients (based on ICD-10) in the year 2017 was first determined. Average direct healthcare expenditures were then assessed in relation to factors such as residence determinants and comorbidities as well as the geographic mobility type of patients by type of care and cancer during the initial phase of care specifically within the 12 months following the initial diagnosis. A two-sided level of statistical significance was set at 0.05. Data analysis was performed with IBM SPSS 21.0 (Statistical Package for Social Sciences).Results: For the year 2017, 100,317 newly diagnosed patients of all cancer types (ICD=C*) in Greece were initially analyzed. By applying inclusion and exclusion criteria, 25,634 newly diagnosed patients (with the four types of cancer under study) were identified: 8,305 patients with breast cancer, 6,605 patients with lung cancer, 5,886 patients with colon cancer, and 4 patients with prostate cancer. The incidence of the studied cancer types increased with increasing patient age (p<0.05).The majority of breast, lung, and colon cancer patients residing in counties with university hospitals (~60%) did not need to travel outside their place of residence to receive healthcare. Additionally, over 66% of prostate cancer patients did not need to travel outside their place of residence to receive health care, although a smaller percentage (<58%) resided in counties with university hospitals. Based on the Internal Demand Satisfaction Index (IDSI), the regions of Attica (IDSI: 28) and Central Macedonia (IDSI: 22) showed the highest degree of satisfaction regarding hospitalizations that include antineoplastic treatments and surgeries, while the regions of Central Greece (IDSI: -80) and the Ionian Islands (IDSI: -79) were at the opposite end. Accordingly, for radiotherapy sessions, the highest internal demand satisfaction index was observed in the region of Attica (IDSI: 19) and Central Macedonia (IDSI: 19), while the lowest was observed in the South Aegean (IDSI: -104) and Western Macedonia (IDSI: -102). The highest mean expenditure per patient during the 12-month follow-up period after diagnosis was for lung cancer (€9,666, SD: 13,296), breast cancer (€7,527, SD: 10,720), and colon cancer (€6,317, SD: 6,775), while the lowest mean expenditure was calculated for prostate cancer patients (€2,611, SD: 3,516). Expenditure on antineoplastic treatments was the main shaper of total healthcare expenditure (48.6%) across all cancer types followed by expenditure on surgical procedures (16.2%). Significant differences were noted in the composition of direct healthcare expenditure between patients with the same type of cancer but different regions of residence. Specifically, breast and lung cancer patients from Crete recorded the highest average costs [Breast: €8,599 in Crete vs €7,527 in Greece, p_value = 0,051]; Lung: €11,068 in Crete vs €9,666 in Greece, p_value = 0,04]. Accordingly, the highest average expenditure among prostate cancer patients was calculated for patients who resided in the region of Western Macedonia [€3,506 vs €2,611 in Greece, p_value = 0,002].Conclusions: The study demonstrated the feasibility of using administrative healthcare data (in the absence of a Neoplasm Registry) to evaluate the accessibility of oncology patients to the appropriate health care and to estimate the corresponding financial burden for the EOPYY. The results obtained will contribute to a more effective redesign of cancer management policies in the country. However, further research is needed to assess cost-effectiveness in relation to clinical outcomes achieved to ensure optimal allocation of healthcare resources.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Priftis, Christos
  • Πρίφτης, Χρήστος

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57682

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Priftis, Christos; Πρίφτης, Χρήστος. Διερεύνηση της προσβασιμότητας των υπηρεσιών υγείας από ασθενείς με κακοήθη νεοπλασματική νόσο και εκτίμηση της οικονομικής επιβάρυνσης του ΕΟΠΥΥ. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/57682